Financial News · Live Terminal

Page 18 of 532

BNP Paribas Adjusts Price Target on eBay to $115 From $110

eBay (EBAY) has an average rating of hold and mean price target of $115.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $111.35, Change: $+0.19, Percent Change: +0.18%

$EBAY

Wire2d ago

Cantor Fitzgerald Adjusts Price Target on eBay to $106 From $110

$EBAY

Wire2d ago

MoffettNathanson Adjusts Price Target on eBay to $103 From $108

$EBAY

Wire2d ago

Privia Health Shares Slide After Q2 Adjusted Earnings Miss

Privia Health (PRVA) shares fell 13% in Thursday trading after the company reported Q2 adjusted earnings that missed Wall Street expectations.The company reported Q2 non-GAAP earnings of $0.19 per diluted share, up from $0.17 a year earlier.Analysts polled by FactSet expected $0.24.Revenue for the quarter ended June 30 was $632.6 million, compared with $521.2 million a year earlier.Analysts polled by FactSet expected $597.3 million.For 2026, the company said it expects GAAP revenue at the high end of its previously issued guidance range of $2.35 billion to $2.45 billion. Analysts surveyed by FactSet expect $2.42 billion.Price: $20.55, Change: $-3.41, Percent Change: -14.23%

$PRVA

Wire2d ago

Rothschild & Co Redburn Adjusts Amgen Price Target to $235 From $220, Maintains Sell Rating

Amgen (AMGN) has an average rating of overweight and mean price target of $375.89, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $411.20, Change: $+3.37, Percent Change: +0.83%

$AMGN

Wire2d ago

Core Natural Resources Shares Rise After Q2 Swings to Profit, Revenue Increases

Core Natural Resources (CNR) shares rose 3.4% in early trading Thursday after its Q2 swung to a profit and revenue increased.The company reported Q2 earnings Thursday of $2.51 per diluted share, swinging from a loss of $0.70 a year earlier.Four analysts polled by FactSet expected $0.60.Revenue for the quarter ended June 30 was $1.14 billion, up from $1.10 billion a year earlier.Four analysts expected $1.11 billion.Price: $86.50, Change: $+2.81, Percent Change: +3.36%

$CNR

Wire2d ago

DA Davidson Adjusts Price Target on Caterpillar to $882 From $845, Maintains Neutral Rating

Caterpillar (CAT) has an average rating of overweight and mean price target of $984.41, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $870.67, Change: $-0.86, Percent Change: -0.10%

$CAT

Wire2d ago

Wedbush Adjusts PT on Viridian Therapeutics to $41 From $43, Maintains Outperform Rating

Viridian Therapeutics (VRDN) has an average rating of buy and mean price target of $36.75, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $21.17, Change: $+0.10, Percent Change: +0.47%

$VRDN

Wire2d ago

Wedbush Adjusts Price Target on Cullinan Therapeutics to $39 From $37, Maintains Outperform Rating

Cullinan Therapeutics (CGEM) has an average rating of buy and mean price target of $32.83, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $17.46, Change: $-0.15, Percent Change: -0.85%

$CGEM

Wire2d ago

Oppenheimer Adjusts Price Target on GXO Logistics to $61 From $66, Maintains Outperform Rating

GXO Logistics (GXO) has an average rating of buy and mean price target of $68.71, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $47.13, Change: $-0.60, Percent Change: -1.26%

$GXO

Wire2d ago

Oppenheimer Adjusts PT on Flutter Entertainment to $120 From $135, Maintains Outperform Rating

Flutter Entertainment (FLUT) has an average rating of overweight and mean price target of $142.08, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $92.30, Change: $-0.61, Percent Change: -0.66%

$FLUT

Wire2d ago

Oppenheimer Adjusts PT on Extreme Networks to $35 From $25, Maintains Outperform Rating

Extreme Networks (EXTR) has an average rating of buy and mean price target of $33.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $24.92, Change: $-1.27, Percent Change: -4.85%

$EXTR

Wire2d ago

Oppenheimer Adjusts PT on Everus Construction to $200 From $185, Maintains Outperform Rating

Everus Construction Group (ECG) has an average rating of overweight and mean price target of $177.40, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $140.96, Change: $+0.06, Percent Change: +0.04%

$ECG

Wire2d ago

Oppenheimer Adjusts Price Target on Corpay to $454 From $388, Maintains Outperform Rating

Corpay (CPAY) has an average rating of overweight and mean price target of $429.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $394.53, Change: $-1.99, Percent Change: -0.50%

$CPAY

Wire2d ago

Oppenheimer Adjusts PT on BrightView Holdings to $16 From $17, Maintains Outperform Rating

BrightView Holdings (BV) has an average rating of overweight and mean price target of $15.65, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $10.49, Change: $-0.12, Percent Change: -1.11%

$BV

Wire2d ago

Scholar Rock Q2 Net Loss Narrows

Scholar Rock (SRRK) reported a Q2 net loss Thursday of $0.84 per diluted share, compared with a loss of $0.98 a year earlier.Analysts polled by FactSet expected a loss of $0.84.As expected, the company reported no revenue for the quarter ended June 30.Cash, cash equivalents, and marketable securities as of June 30 totaled $492.1 million.Shares of the company were up over 6% in Thursday premarket activity.Price: $50.93, Change: $+3.06, Percent Change: +6.40%

$SRRK

Wire2d ago

Insmed Q2 Loss Narrows, Revenue Rises; Shares Up Pre-Bell

Insmed (INSM) reported a Q2 loss Thursday of $0.06 per share, narrowing from a loss of $1.70 a year earlier.Analysts polled by FactSet expected a loss of $0.69.Revenue for the quarter ended June 30 was $425.5 million, up from $107.4 million a year earlier.An analyst polled by FactSet expected $425.5 million.For 2026, Insmed raised its Brinsupri revenue guidance to a range of $1.25 billion to $1.40 billion from its prior outlook of at least $1 billion, while reiterating Arikayce revenue guidance of $450 million to $470 million.Insmed shares were over 21% higher in premarket activity Thursday.Price: $120.60, Change: $+21.58, Percent Change: +21.79%

$INSM

Wire2d ago

Oscar Health Swings to Q2 Profit, Revenue Rises; 2026 Revenue Outlook Reaffirmed

Oscar Health (OSCR) reported Q2 earnings Thursday of $1.10 per diluted share, compared with a loss of $0.89 a year earlier.Analysts surveyed by FactSet expected $0.40.Revenue for the quarter ended June 30 was $4.88 billion, up from $2.86 billion a year earlier.Analysts expected $4.73 billion.The company said it continues to expect 2026 revenue of $18.7 billion to $19 billion. Analysts are looking for $12.48 billion.Shares of the company rose more than 16% in recent premarket activity Thursday.Price: $35.10, Change: $+4.99, Percent Change: +16.57%

$OSCR

Wire2d ago

UWM Holdings Shares Fall Pre-Bell Amid Swing to Q2 Adjusted Loss

UWM Holdings (UWMC) shares fell more than 18% in recent premarket activity Thursday after the company swung to an adjusted loss in Q2.The company reported late Wednesday an adjusted Q2 loss of $0.23 per diluted share, swinging from an adjusted EPS of $0.16 a year earlier.Analysts polled by FactSet expected adjusted EPS of $0.07.Revenue for the quarter ended June 30 was $888 million, up from $758.7 million a year ago. Analysts expected $727.5 million.Separately, UWM Holdings secured a $2.05 billion investment under a strategic capital partnership with SFS Group Capital and Oaktree Capital Management, according to a Wednesday statement.Preferred equity and warrants were issued for the initial investment, UWM said.The company also plans to launch a $400 million rights offering to class A shareholders, backed by the two new investors, if needed, according to the statement.In addition, UWM said it will suspend common dividends to prioritize debt reduction and boost its balance sheet.Price: $1.50, Change: $-0.34, Percent Change: -18.48%

$UWMC

Wire2d ago

Cirrus Logic Fiscal Q1 Adjusted Earnings, Revenue Rise

Cirrus Logic (CRUS) reported fiscal Q1 adjusted earnings late Wednesday of $1.84 per diluted share, up from $1.51 a year earlier.Analysts polled by FactSet expected $1.81.Revenue in the three months ended June 27 rose to $459.7 million from $407.3 million a year ago.Four analysts expected $460.3 million.The company expects fiscal Q2 revenue of $510 million to $570 million. Analysts project $570.1 million.Cirrus Logic shares fell 3.4% in after-hours trading.

$CRUS

Showing 341-360 of 10633